Elan reports net loss of $213m in second quarter
Jul 22nd, 2010 | By Finfacts Ireland Business & Finance Portal | Category: News worldwide
Irish drugs firm Elan today reported a net loss of $213m in the second quarter but an improved operating performance. Its financial results were hit by the recent $206.3m fine and costs arising from the mis-marketing of the product Zonegran.